GlassScriptPhysician profile
Kayla Batchelor
NPI 1760968267
$471.97
in general payments reported to CMS, 2019-2025
8 companies · $69.98 in 2025
The $69.98 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.71 · 2020: $11.62 · 2021: $90.93 · 2022: $119 · 2023: $61.73 · 2024: $80.72 · 2025: $69.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $163.82 | 2021-2022 | |
| Abbvie INC. | $63.54 | 2019-2025 | |
| Pfizer INC. | $59.62 | 2021-2024 | |
| Gilead Sciences, INC. | $59.61 | 2024-2025 | |
| Inspire Medical Systems, INC. | $48.07 | 2023 | Inspire |
| Lilly USA, LLC | $47.85 | 2021-2024 | Mounjaro, Zepbound |
| Allergan, INC. | $17.84 | 2019 | |
| Redhill Biopharma INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Batchelor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.